JMP Securities believes the manufacturer of an atrial fibrillation device could experience a 70% increase in value.

Shares of medical device provider AtriCure are a lucrative investment opportunity, according to JMP Securities. Analyst Daniel Stauder initiated coverage of the stock with an outperform rating and a price target of $60, suggesting that the shares could increase by almost 70%. Stauder stated that AtriCure is the leading player in treating complex forms of…

Read More

Strategies to approach stock play as Amazon’s falls leading up to earnings results next week.

Amazon Faces Investor Reaction Ahead of Earnings Report Investors and analysts are closely watching Amazon as the e-commerce giant prepares to release its earnings report next Thursday. Market Movers, a leading platform for financial research, recently gathered the latest reactions from experts in the industry. The Nasdaq Composite, dominated by tech stocks like Amazon, experienced…

Read More